Product overview
Name | A 83-01 |
Description | Selective TGF-βRI (ALK5), ALK4 and ALK7 inhibitor. Maintains human hiPSC self renewal, 3D growth matrix component and promotes long-term organoid growth. Aids fibroblast to NSC/cardiomyocyte reprogramming. |
Alternative names | A83 |
Purity | >98% |
Customer comments | : Good quality and very affordable price. My lab are very happy with this product from Hello Bio, we will definitely purchase this product again. Verified customer, UK |
Images
Biological Data
Biological description | A 83-01 is a selective TGF-βRI (ALK5), ALK4 and ALK7 inhibitor (IC50 values are 12, 45 and 7.5 nM at ALK5, ALK4 and ALK7 respectively). It is more potent than SB431542 Reprogramming A 83-01 aids reprogramming of fibroblasts into neural stem cells and cardiomyocytes.
A 83-01 blocks phosphorylation of SMAD2/3 to inhibit TGF-β-induced epithelial-to-mesenchymal transition
A 83-01 helps to maintain homogeneity and long-term in vitro self-renewal of iPSCs
3D growth matrix component and also promotes long-term organoid growth. |
Application notes | Figures 1 - 3 show liver hepatocellular carcinoma tumouroids cultured with A 83-01 and forskolin |
Solubility & Handling
Storage instructions | -20°C (protect from light) |
Solubility overview | Soluble in DMSO (50mM) |
Handling |
|
Important | This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use. |
Chemical Data
Chemical name | 3-(6-Methyl-2-pyridinyl)-N-phenyl-4 -(4-quinolinyl)-1H-pyrazole-1-carbothioamide |
Molecular Weight | 421.52 |
Chemical structure | |
Molecular Formula | C25H19N5S |
CAS Number | 909910-43-6 |
PubChem identifier | 16218924 |
SMILES | CC1=CC=CC(=N1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5 |
InChi | InChI=1S/C25H19N5S/c1-17-8-7-13-23(27-17)24-21(19-14-15-26-22-12-6-5-11-20(19)22)16-30(29-24)25(31)28-18-9-3-2-4-10-18/h2-16H,1H3,(H,28,31) |
InChiKey | HIJMSZGHKQPPJS-UHFFFAOYSA-N |
Appearance | Pale yellow solid |
References for A 83-01
-
Chemical compound-based direct reprogramming for future clinical applications.
Takeda et al (2018) Biosci Rep 38(3) : pii: BSR20171650 -
Brief report: combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts.
Yuan et al (2011) 2011 29(3) : 549-53 -
Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors.
Li et al (2009) Cell Stem Cell 4(1) : 16-9 -
The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta.
Tojo et al (2005) Cancer Sci 96(11) : 791-800